Optimizing assessments of quality of life in contemporary prostate cancer clinical trials

被引：0
|
作者：
Morgans, Alicia K. [1 ,2 ]
机构：
[1] Harvard Med Sch, Dept Med, 450 Brookline Ave,DA 09-930, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, 450 Brookline Ave,DA 09-930, Boston, MA 02215 USA
来源：
CANCER | 2024年 / 130卷 / 20期
关键词：
PATIENT-REPORTED OUTCOMES; THERAPY;
D O I：
10.1002/cncr.35485
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This editorial reviews the associations between quality of life (QOL) and prognosis in cancer clinical trials, and considers whether they may be different in the era of radioligand therapy. It also outlines novel approaches to QOL analysis that may enhance our ability to use patient-reported outcomes in treatment decisions more effectively in the future.
引用
收藏
页码：3406 / 3408
页数：3
相关论文
共 50 条
12345